Sugammadex in patients with myasthenia gravis.

Reversal of rocuronium-induced (1.2 mg kg-1) profound neuromuscular block by accidental high dose of sugammadex (40 mg kg-1).

Molina, A.L.
Boer, H.D. de
Klimek, M.
Heeringa, M.
Klein, J.

January 2007

Contains fulltext : 51844.pdf (publisher's version ) (Closed access)Sugammadex is ...

Cyclodextrins and the emergence of sugammadex.

Booij, L.H.D.J.

January 2009

Contains fulltext : 79529.pdf (publisher's version ) (Closed access)Residual paral...

Persistent increased risk for thymoma in myasthenia gravis associated with myositis.

Hengstman, G.J.D.
Drost, G.
Wagenaar, M.
Engelen, B.G.M. van

January 2006

Contains fulltext : 51007.pdf (publisher's version ) (Closed access

Update on the management of neuromuscular block-focus on sugammadex.

Boer, H.D. de
Egmond, J. van
Driessen, J.J.
Booij, L.H.D.J.

January 2007

Contains fulltext : 52422.pdf (publisher's version ) (Open Access

A new approach to anesthesia management in myasthenia gravis: reversal of neuromuscular blockade by sugammadex.

Boer, H.D. de
Egmond, J. van
Driessen, J.J.
Booij, L.H.D.J.

January 2010

Item does not contain fulltextA neuromuscular blocking drug (NMBD) induced neuromuscular blockade (N...

Sugammadex, a new reversal agent for rocuronium induced neuromuscular block. A step forward in improving patient's safety.

Boer, H.D. de

January 2008

Contains fulltext : 70921.pdf (publisher's version ) (Open Access)RU Radboud Unive...

Non-steroidal neuromuscular blocking agents to re-establish paralysis after reversal of rocuronium-induced neuromuscular block with sugammadex.

Boer, H.D. de
Driessen, J.J.
Egmond, J. van
Booij, L.H.D.J.

January 2008

Contains fulltext : 71170.pdf (publisher's version ) (Closed access

Use of sugammadex in patients with neuromuscular disorders: a systematic review of case reports

Gurunathan, Usha
Kunju, Shakeel Meeran
Stanton, Lisa May Lin

November 2019

Sugammadex is a modified gamma-cyclodextrin that acts by selectively encapsulating free amino-steroi...

Reversal of rocuronium-induced profound neuromuscular block by sugammadex in Duchenne muscular dystrophy.

Boer, H.D. de
Egmond, J. van
Booij, L.H.D.J.
Driessen, J.J.

January 2009

Contains fulltext : 81674.pdf (publisher's version ) (Closed access)A case is repo...

Sugammadex in renal failure

Staals, L.M.

January 2011

Contains fulltext : 89942.pdf (publisher's version ) (Open Access)Radboud Universi...

Successful use of sugammadex for caesarean section in a patient with myasthenia gravis

Lokman Soyoral
Ugur Goktas
Muhammed Bilal Cegin
Volkan Baydi

March 2017

Myasthenia gravis is an autoimmune disorder that is characterized by muscle weakness that fluctuates...

Successful use of sugammadex for caesarean section in a patient with myasthenia gravis

Soyoral, Lokman
Goktas, Ugur
Cegin, Muhammed Bilal
Baydi, Volkan

November 2014

AbstractMyasthenia gravis is an autoimmune disorder that is characterized by muscle weakness that fl...

Neuromuscular transmission: new concepts and agents.

Boer, H.D. de

January 2009

Contains fulltext : 81109.pdf (publisher's version ) (Closed access)Sugammadex is ...

Sugammadex use in a patient with myastenia gravis

Ebru Biricik

January 2016

Myastenia gravis nöromüsküler kavşağı tutan otoimmün bir hastalıktır ve bu tanıyı alan hastalarda op...

Neuromuscular block reversal with sugammadex in a morbidly obese patient with myasthenia gravis

Jakubiak, Jakub
Gaszyński, Tomasz
Gaszyński, Wojciech

March 2012

BACKGRAOUND: Myasthenia gravis is a rare immunological illness that impairs neuromuscular transmissi...

Reversal of rocuronium-induced (1.2 mg kg-1) profound neuromuscular block by accidental high dose of sugammadex (40 mg kg-1).

Molina, A.L.
Boer, H.D. de
Klimek, M.
Heeringa, M.
Klein, J.

January 2007

Contains fulltext : 51844.pdf (publisher's version ) (Closed access)Sugammadex is ...

Cyclodextrins and the emergence of sugammadex.

Booij, L.H.D.J.

January 2009

Contains fulltext : 79529.pdf (publisher's version ) (Closed access)Residual paral...

Persistent increased risk for thymoma in myasthenia gravis associated with myositis.

Hengstman, G.J.D.
Drost, G.
Wagenaar, M.
Engelen, B.G.M. van

January 2006

Contains fulltext : 51007.pdf (publisher's version ) (Closed access

Update on the management of neuromuscular block-focus on sugammadex.

Boer, H.D. de
Egmond, J. van
Driessen, J.J.
Booij, L.H.D.J.

January 2007

Contains fulltext : 52422.pdf (publisher's version ) (Open Access

A new approach to anesthesia management in myasthenia gravis: reversal of neuromuscular blockade by sugammadex.

Boer, H.D. de
Egmond, J. van
Driessen, J.J.
Booij, L.H.D.J.

January 2010

Item does not contain fulltextA neuromuscular blocking drug (NMBD) induced neuromuscular blockade (N...

Sugammadex, a new reversal agent for rocuronium induced neuromuscular block. A step forward in improving patient's safety.

Boer, H.D. de

January 2008

Contains fulltext : 70921.pdf (publisher's version ) (Open Access)RU Radboud Unive...

Non-steroidal neuromuscular blocking agents to re-establish paralysis after reversal of rocuronium-induced neuromuscular block with sugammadex.

Boer, H.D. de
Driessen, J.J.
Egmond, J. van
Booij, L.H.D.J.

January 2008

Contains fulltext : 71170.pdf (publisher's version ) (Closed access

Use of sugammadex in patients with neuromuscular disorders: a systematic review of case reports

Gurunathan, Usha
Kunju, Shakeel Meeran
Stanton, Lisa May Lin

November 2019

Sugammadex is a modified gamma-cyclodextrin that acts by selectively encapsulating free amino-steroi...

Reversal of rocuronium-induced profound neuromuscular block by sugammadex in Duchenne muscular dystrophy.

Boer, H.D. de
Egmond, J. van
Booij, L.H.D.J.
Driessen, J.J.

January 2009

Contains fulltext : 81674.pdf (publisher's version ) (Closed access)A case is repo...

Sugammadex in renal failure

Staals, L.M.

January 2011

Contains fulltext : 89942.pdf (publisher's version ) (Open Access)Radboud Universi...

Successful use of sugammadex for caesarean section in a patient with myasthenia gravis

Lokman Soyoral
Ugur Goktas
Muhammed Bilal Cegin
Volkan Baydi

March 2017

Myasthenia gravis is an autoimmune disorder that is characterized by muscle weakness that fluctuates...

Successful use of sugammadex for caesarean section in a patient with myasthenia gravis

Soyoral, Lokman
Goktas, Ugur
Cegin, Muhammed Bilal
Baydi, Volkan

November 2014

AbstractMyasthenia gravis is an autoimmune disorder that is characterized by muscle weakness that fl...

Neuromuscular transmission: new concepts and agents.

Boer, H.D. de

January 2009

Contains fulltext : 81109.pdf (publisher's version ) (Closed access)Sugammadex is ...

Sugammadex use in a patient with myastenia gravis

Ebru Biricik

January 2016

Myastenia gravis nöromüsküler kavşağı tutan otoimmün bir hastalıktır ve bu tanıyı alan hastalarda op...

Neuromuscular block reversal with sugammadex in a morbidly obese patient with myasthenia gravis

Jakubiak, Jakub
Gaszyński, Tomasz
Gaszyński, Wojciech

March 2012

BACKGRAOUND: Myasthenia gravis is a rare immunological illness that impairs neuromuscular transmissi...

Reversal of rocuronium-induced (1.2 mg kg-1) profound neuromuscular block by accidental high dose of sugammadex (40 mg kg-1).

Molina, A.L.
Boer, H.D. de
Klimek, M.
Heeringa, M.
Klein, J.

January 2007

Contains fulltext : 51844.pdf (publisher's version ) (Closed access)Sugammadex is ...

Cyclodextrins and the emergence of sugammadex.

Booij, L.H.D.J.

January 2009

Contains fulltext : 79529.pdf (publisher's version ) (Closed access)Residual paral...

Persistent increased risk for thymoma in myasthenia gravis associated with myositis.

Hengstman, G.J.D.
Drost, G.
Wagenaar, M.
Engelen, B.G.M. van

January 2006

Contains fulltext : 51007.pdf (publisher's version ) (Closed access

Sugammadex in patients with myasthenia gravis.

Abstract

Extracted data

Sugammadex in patients with myasthenia gravis.

Abstract

Extracted data

Related items

Related items